The NH-BMT Program diagnoses and treats the following hematological disorders:
Acute Myelogeneous Leukemia (AML)- Acute Lymphoblastic Leukemia (ALL)
- Amyloidosis
- Anaplastic Lymphoblastic Lymphoma
- Aplastic Anemia
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Hereditary Hemoglobinopathies (Thalassemia, Sickle Cell)
- Hodgkin Disease
- Myelodysplastic Syndrome
- Multiple Myeloma
- Non-Hodgkin Lymphoma (NHL)
- Solid Tumors amenable to transplant therapy
- Waldenstroms Macroglobulinemia